Related Experiment Video
Updated: Jan 9, 2026

Construction of Cyclic Cell-Penetrating Peptides for Enhanced Penetration of Biological Barriers
Published on: September 19, 2022
Bicyclic peptide-based CPPTACs for extracellular and cell membrane protein degradation.
Jinyu Bai1, Huaihuai Shi2, Jitun Chen3
1Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen 518055, China; Guangdong Key Laboratory of Nanomedicine, CAS-HK Joint Lab of Biomaterials, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.
New bicyclic peptide-based lysosome-targeting chimeras (CPPTACs) effectively degrade extracellular and cell surface proteins. This targeted protein degradation strategy enhances cellular uptake and shows promise for pharmaceutical drug discovery.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Discovery
Background:
- Extracellular and cell membrane proteins are vital for physiological balance.
- Aberrant expression of these proteins is linked to various diseases.
- Targeted degradation of these proteins presents a significant therapeutic avenue.
Purpose of the Study:
- To develop novel bicyclic peptide-based lysosome-targeting chimeras (CPPTACs).
- To selectively degrade extracellular and cell surface proteins using CPPTACs.
- To leverage cell-penetrating peptide (CPP)-induced endocytosis and lysosomal delivery.
Main Methods:
- Conjugation of a bicyclic CPP with the KRK motif to target protein-binding molecules.
- Utilizing CPPTACs to induce endocytosis and lysosomal delivery.
- Assessing cellular uptake and protein degradation efficacy.
Main Results:
- Bicyclic peptide-based CPPTACs demonstrated enhanced cellular uptake.
- CPPTACs facilitated rapid degradation of target proteins via the endo-lysosomal pathway.
- Successful selective degradation of extracellular and cell surface proteins was achieved.
Conclusions:
- Bicyclic peptide-based CPPTACs are effective tools for targeted protein degradation.
- This strategy enhances cellular uptake and lysosomal delivery for protein elimination.
- CPPTACs hold potential for advancing pharmaceutical drug discovery and therapeutic development.
More Related Videos
05:33High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
Published on: November 9, 2020
08:48Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
Published on: January 26, 2016
Related Concept Videos
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Caspases
Anaphase Promoting Complex
ER Retrieval Pathway
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...